Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia

Description

Multi center, retrospective chart review of patients admitted to MHS hospitals from April 1, 2017 to March 31, 2022. Patients will be identified through the electronic medical record, and data from those that meet the study inclusion and exclusion criteria will be analyzed. Minimum inhibitory concentration (MIC) data will be interpreted per Clinical \& Laboratory Standards Institute (CLSI) standards to determine local patterns of resistance. Multivariable logistic regression will be performed to determine predictors of mortality for S. maltophilia isolates.

Conditions

Stenotrophomonas Maltophilia Infection

Study Overview

Study Details

Study overview

Multi center, retrospective chart review of patients admitted to MHS hospitals from April 1, 2017 to March 31, 2022. Patients will be identified through the electronic medical record, and data from those that meet the study inclusion and exclusion criteria will be analyzed. Minimum inhibitory concentration (MIC) data will be interpreted per Clinical \& Laboratory Standards Institute (CLSI) standards to determine local patterns of resistance. Multivariable logistic regression will be performed to determine predictors of mortality for S. maltophilia isolates.

Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia

Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia

Condition
Stenotrophomonas Maltophilia Infection
Intervention / Treatment

-

Contacts and Locations

Dallas

Methodist Dallas Medical Center, Dallas, Texas, United States, 75201

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * ≥18 years of age
  • * S. maltophilia isolated on respiratory or blood culture
  • * Those that do not meet the inclusion criteria outlined in Section 4.1.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Methodist Health System,

Mathew Crotty, PharmD, PRINCIPAL_INVESTIGATOR, Methodist Dallas Medical Center

Study Record Dates

2024-07-21